Proteome of metastatic canine mammary carcinomas: Similarities to and differences from human breast cancer

Journal of Proteome Research

Volumn 9, Issue 12, 2010, Pages 6380-6391

  Klopfleisch, Robert ^a   Klose, Patricia ^a   Weise, Christoph ^a   Bondzio, Angelika ^a   Multhaup, Gerd ^a   Einspanier, Ralf ^a   Gruber, Achim D ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ALPHA TROPOMYOSIN; CALRETININ; CYCLINE; FERRITIN; ISOCITRATE DEHYDROGENASE 1; LIPOCORTIN 5; MASPIN; MYOSIN; MYOSIN LIGHT CHAIN 2; ORNITHINE OXOACID AMINOTRANSFERASE; PEROXIREDOXIN 6; PROTEOME; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; VINCULIN;

ANIMAL CELL; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CELL ADHESION; CONTROLLED STUDY; DOG; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METASTASIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

AMINO ACID SEQUENCE; ANIMALS; BREAST NEOPLASMS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; DOGS; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, ANIMAL; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEOME; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, AMINO ACID; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

CANIS FAMILIARIS; EUKARYOTA;

EID: 78649676210     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr100671c     Document Type: Article

References (91)

1. Schulz, D. M.; Bollner, C.; Thomas, G.; Atkinson, M.; Esposito, I.; Hofler, H.; Aubele, M. Identification of differentially expressed proteins in triple-negative breast carcinomas using DIGE and mass spectrometry J. Proteome Res. 2009, 8 (7) 3430-8
2. Hondermarck, H.; Vercoutter-Edouart, A. S.; Revillion, F.; Lemoine, J.; el-Yazidi-Belkoura, I.; Nurcombe, V.; Peyrat, J. P. Proteomics of breast cancer for marker discovery and signal pathway profiling Proteomics 2001, 1 (10) 1216-32
3. Li, D. Q.; Wang, L.; Fei, F.; Hou, Y. F.; Luo, J. M.; Zeng, R.; Wu, J.; Lu, J. S.; Di, G. H.; Ou, Z. L.; Xia, Q. C.; Shen, Z. Z.; Shao, Z. M. Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry Proteomics 2006, 6 (11) 3352-68
4. Bartkowiak, K.; Wieczorek, M.; Buck, F.; Harder, S.; Moldenhauer, J.; Effenberger, K. E.; Pantel, K.; Peter-Katalinic, J.; Brandt, B. H. Two-Dimensional Differential Gel Electrophoresis of a Cell Line Derived from a Breast Cancer Micrometastasis Revealed a Stem/Progenitor Cell Protein Profile. J. Proteome Res. 2009, 8, 2004 - 2014.
5. Raval, G. N.; Bharadwaj, S.; Levine, E. A.; Willingham, M. C.; Geary, R. L.; Kute, T.; Prasad, G. L. Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors Oncogene 2003, 22 (40) 6194-203
6. Espinosa de los Monteros, A.; Millan, M. Y.; Ramirez, G. A.; Ordas, J.; Reymundo, C.; Martin de las Mulas, J. Expression of maspin in mammary gland tumors of the dog Vet. Pathol. 2005, 42 (3) 250-7
7. Sager, R.; Sheng, S.; Pemberton, P.; Hendrix, M. J. Maspin. A tumor suppressing serpin Adv. Exp. Med. Biol. 1997, 425, 77-88
8. Stark, A. M.; Schem, C.; Maass, N.; Hugo, H. H.; Jonat, W.; Mehdorn, H. M.; Held-Feindt, J. Expression of metastasis suppressor gene maspin is reduced in breast cancer brain metastases and correlates with the estrogen receptor status. Neurol. Res. 2010, 32, 303 - 308.
9. Toillon, R. A.; Lagadec, C.; Page, A.; Chopin, V.; Sautiere, P. E.; Ricort, J. M.; Lemoine, J.; Zhang, M.; Hondermarck, H.; Le Bourhis, X. Proteomics demonstration that normal breast epithelial cells can induce apoptosis of breast cancer cells through insulin-like growth factor-binding protein-3 and maspin Mol. Cell. Proteomics 2007, 6 (7) 1239-47
10. Khanna, C.; Hunter, K. Modeling metastasis in vivo Carcinogenesis 2005, 26 (3) 513-23
11. Vail, D. M.; MacEwen, E. G. Spontaneously occurring tumors of companion animals as models for human cancer Cancer Invest. 2000, 18 (8) 781-92
12. Khanna, C.; Lindblad-Toh, K.; Vail, D.; London, C.; Bergman, P.; Barber, L.; Breen, M.; Kitchell, B.; McNeil, E.; Modiano, J. F.; Niemi, S.; Comstock, K. E.; Ostrander, E.; Westmoreland, S.; Withrow, S. The dog as a cancer model Nat. Biotechnol. 2006, 24 (9) 1065-6
13. Benson, J. R. Role of transforming growth factor beta in breast carcinogenesis Lancet Oncol. 2004, 5 (4) 229-39
14. Klopfleisch, R.; Schutze, M.; Gruber, A. D. Downregulation of transforming growth factor beta (TGFbeta) and latent TGFbeta binding protein (LTBP)-4 expression in late stage canine mammary tumours. Vet. J. 2009.
15. Klopfleisch, R.; Schutze, M.; Gruber, A. D. RAD51 protein expression is increased in canine mammary carcinomas. Vet. Pathol. 47, (1), 98 - 101.
16. Maacke, H.; Opitz, S.; Jost, K.; Hamdorf, W.; Henning, W.; Kruger, S.; Feller, A. C.; Lopens, A.; Diedrich, K.; Schwinger, E.; Sturzbecher, H. W. Over-expression of wild-type Rad51 correlates with histological grading of invasive ductal breast cancer Int. J. Cancer 2000, 88 (6) 907-13
17. Klopfleisch, R.; Gruber, A. D. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas J. Comp. Pathol. 2009, 141 (2-3) 113-20
18. Klopfleisch, R.; Schutze, M.; Linzmann, H.; Brunnberg, L.; Gruber, A. D. Increased Derlin-1 Expression in Metastases of Canine Mammary Adenocarcinomas. J. Comp. Pathol. 2009.
19. Wang, J.; Hua, H.; Ran, Y.; Zhang, H.; Liu, W.; Yang, Z.; Jiang, Y. Derlin-1 is overexpressed in human breast carcinoma and protects cancer cells from endoplasmic reticulum stress-induced apoptosis Breast Cancer Res. 2008, 10 (1) R7
20. Klopfleisch, R.; Schutze, M.; Gruber, A. D. Loss of p27 expression in canine mammary tumors and their metastases Res. Vet. Sci. 2010, 88 (2) 300-303
21. Viglietto, G.; Motti, M. L.; Fusco, A. Understanding p27(kip1) deregulation in cancer: down-regulation or mislocalization Cell Cycle 2002, 1 (6) 394-400
22. Klopfleisch, R.; Gruber, A. D. Differential expression of cell cycle regulators p21, p27 and p53 in metastasizing canine mammary adenocarcinomas versus normal mammary glands Res. Vet. Sci. 2009, 87 (1) 91-6
23. Klopfleisch, R.; Gruber, A. D. Increased Expression of BRCA2 and RAD51 in Lymph Node Metastases of Canine Mammary Adenocarcinomas Vet. Pathol. 2009, 46 (3) 416-22
24. Misdorp, W. Tumors of the mammary gland. In Tumours in Domestic Animals, 4th ed.; Meuten, D. J., Ed.; Iowa State Press: IA, 2002; pp 575 - 606.
25. de Las Mulas, J. M.; Millan, Y.; Dios, R. A prospective analysis of immunohistochemically determined estrogen receptor alpha and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog Vet. Pathol. 2005, 42 (2) 200-12
26. Kitchell, B. E. a. L., A. S. Diseases of the mammary glands. In Handbook of Small Animal Practice, 3rd ed.; Morgan, R. V., Ed., W.B. Saunders: Philadelphia, 1997; pp 615 - 625.
27. Misdorp, W.; Else, R. W.; Hellmén, E.; Lipscomb, T. P. Histological classification of mammary tumors of the dog and the cat; Armed Forces Institute of Pathology: WA, 1999; Vol. 7, pp 9 - 22.
28. Misdorp, W.; Hart, A. A. Canine mammary cancer. I. Prognosis J. Small Anim. Pract. 1979, 20 (7) 385-94
29. Benjamin, S. A.; Lee, A. C.; Saunders, W. J. Classification and behavior of canine mammary epithelial neoplasms based on life-span observations in beagles Vet. Pathol. 1999, 36 (5) 423-36
30. Misdorp, W.; Hart, A. A. Prognostic factors in canine mammary cancer J. Natl. Cancer Inst. 1976, 56 (4) 779-86
31. Shevchenko, A.; Wilm, M.; Vorm, O.; Mann, M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels Anal. Chem. 1996, 68 (5) 850-8
32. Suckau, D.; Resemann, A.; Schuerenberg, M.; Hufnagel, P.; Franzen, J.; Holle, A. A novel MALDI LIFT-TOF/TOF mass spectrometer for proteomics Anal. Bioanal. Chem. 2003, 376 (7) 952-65
33. Livak, K. J.; Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 2001, 25 (4) 402-8
34. Vandesompele, J.; De Preter, K.; Pattyn, F.; Poppe, B.; Van Roy, N.; De Paepe, A.; Speleman, F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome Biol. 2002, 3 (7) RESEARCH0034
35. Etschmann, B.; Wilcken, B.; Stoevesand, K.; von der Schulenburg, A.; Sterner-Kock, A. Selection of reference genes for quantitative real-time PCR analysis in canine mammary tumors using the GeNorm algorithm Vet. Pathol. 2006, 43 (6) 934-42
36. Ogawa, K.; Utsunomiya, T.; Mimori, K.; Tanaka, Y.; Tanaka, F.; Inoue, H.; Murayama, S.; Mori, M. Clinical significance of elongation factor-1 delta mRNA expression in oesophageal carcinoma Br. J. Cancer 2004, 91 (2) 282-6
37. Klopfleisch, R.; Klose, P.; da Costa, A.; Brunnberg, L.; Gruber, A. D. HEPACAM1 and 2 are differentially regulated in canine mammary adenomas and carcinomas and its lymph node metastases. BMC Vet. Res. 2010, 6, 15.
38. Munson, L.; Moresco, A. Comparative pathology of mammary gland cancers in domestic and wild animals Breast Dis. 2007, 28, 7-21
39. Pena, L. L.; Nieto, A. I.; Perez-Alenza, D.; Cuesta, P.; Castano, M. Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables J. Vet. Diagn. Invest. 1998, 10 (3) 237-46
40. Leonardi, E.; Girlando, S.; Serio, G.; Mauri, F. A.; Perrone, G.; Scampini, S.; Dalla Palma, P.; Barbareschi, M. PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables J. Clin. Pathol. 1992, 45 (5) 416-9
41. Moldovan, G. L.; Pfander, B.; Jentsch, S. PCNA, the maestro of the replication fork Cell 2007, 129 (4) 665-79
42. He, X.; Wei, C.; Song, T.; Yuan, J.; Zhang, Y.; Ma, Q.; Shi, W.; Zhong, H. Proliferating cell nuclear antigen destabilizes c-Abl tyrosine kinase and regulates cell apoptosis in response to DNA damage Apoptosis 2009, 14 (3) 268-75
43. Rensen, W. M.; Roscioli, E.; Tedeschi, A.; Mangiacasale, R.; Ciciarello, M.; Di Gioia, S. A.; Lavia, P. RanBP1 downregulation sensitizes cancer cells to taxol in a caspase-3-dependent manner Oncogene 2009, 28 (15) 1748-58
44. Milano, J., Jr.; Strayer, D. S. Effects of overexpression of Ran/TC4 mammalian cells in vitro Exp. Cell Res. 1998, 239 (1) 31-9
45. Emberley, E. D.; Gietz, R. D.; Campbell, J. D.; HayGlass, K. T.; Murphy, L. C.; Watson, P. H. RanBPM interacts with psoriasin in vitro and their expression correlates with specific clinical features in vivo in breast cancer BMC Cancer 2002, 2, 28
46. Joseph, P.; Lei, Y. X.; Whong, W. Z.; Ong, T. M. Oncogenic potential of mouse translation elongation factor-1 delta, a novel cadmium-responsive proto-oncogene J. Biol. Chem. 2002, 277 (8) 6131-6
47. Kolettas, E.; Lymboura, M.; Khazaie, K.; Luqmani, Y. Modulation of elongation factor-1 delta (EF-1 delta) expression by oncogenes in human epithelial cells Anticancer Res. 1998, 18 (1A) 385-92
48. Yang, S.; Du, J.; Wang, Z.; Yuan, W.; Qiao, Y.; Zhang, M.; Zhang, J.; Gao, S.; Yin, J.; Sun, B.; Zhu, T. BMP-6 promotes E-cadherin expression through repressing deltaEF1 in breast cancer cells BMC Cancer 2007, 7, 211
49. Pinho, S. S.; Matos, A. J.; Lopes, C.; Marcos, N. T.; Carvalheira, J.; Reis, C. A.; Gartner, F. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression BMC Cancer 2007, 7, 124
50. Mierke, C. T.; Kollmannsberger, P.; Zitterbart, D. P.; Diez, G.; Koch, T. M.; Marg, S.; Ziegler, W. H.; Goldmann, W. H.; Fabry, B. Vinculin facilitates cell invasion into 3D collagen matrices. J. Biol. Chem.
51. Rodriguez Fernandez, J. L.; Geiger, B.; Salomon, D.; Sabanay, I.; Zoller, M.; Ben-Ze'ev, A. Suppression of tumorigenicity in transformed cells after transfection with vinculin cDNA. J. Cell Biol. 1992, 119 (2), 427 - 38.
52. Scibelli, A.; d'Angelo, D.; Pelagalli, A.; Tafuri, S.; Avallone, L.; Della Morte, R.; Staiano, N. Expression levels of the focal adhesion-associated proteins paxillin and p130CAS in canine and feline mammary tumors Vet. Res. 2003, 34 (2) 193-202
53. He, Q. Y.; Chen, J.; Kung, H. F.; Yuen, A. P.; Chiu, J. F. Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics Proteomics 2004, 4 (1) 271-8
54. Bohling, S. D.; Jenson, S. D.; Crockett, D. K.; Schumacher, J. A.; Elenitoba-Johnson, K. S.; Lim, M. S. Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma Leuk. Res. 2008, 32 (3) 383-93
55. Choi, H. S.; Yim, S. H.; Xu, H. D.; Jung, S. H.; Shin, S. H.; Hu, H. J.; Jung, C. K.; Choi, J. Y.; Chung, Y. J. Tropomyosin3 overexpression and a potential link to epithelial-mesenchymal transition in human hepatocellular carcinoma BMC Cancer 2010, 10, 122
56. Choi, H. S.; Yim, S. H.; Xu, H. D.; Jung, S. H.; Shin, S. H.; Hu, H. J.; Jung, C. K.; Choi, J. Y.; Chung, Y. J. Tropomyosin3 overexpression and a potential link to epithelial-mesenchymal transition in human hepatocellular carcinoma. BMC Cancer 2010, 10, 122.
57. Uetrecht, A. C.; Bear, J. E. Coronins: the return of the crown Trends Cell Biol. 2006, 16 (8) 421-6
58. Gerisch, G.; Albrecht, R.; Heizer, C.; Hodgkinson, S.; Maniak, M. Chemoattractant-controlled accumulation of coronin at the leading edge of Dictyostelium cells monitored using a green fluorescent protein-coronin fusion protein Curr. Biol. 1995, 5 (11) 1280-5
59. Wu, L.; Peng, C. W.; Hou, J. X.; Zhang, Y. H.; Chen, C.; Chen, L. D.; Li, Y. Coronin-1C is a novel biomarker for hepatocellular carcinoma invasive progression identified by proteomics analysis and clinical validation J. Exp. Clin. Cancer Res. 2010, 29, 17
60. Thal, D.; Xavier, C. P.; Rosentreter, A.; Linder, S.; Friedrichs, B.; Waha, A.; Pietsch, T.; Stumpf, M.; Noegel, A.; Clemen, C. Expression of coronin-3 (coronin-1C) in diffuse gliomas is related to malignancy J. Pathol. 2008, 214 (4) 415-24
61. Roadcap, D. W.; Clemen, C. S.; Bear, J. E. The role of mammalian coronins in development and disease Subcell. Biochem. 2008, 48, 124-35
62. Gines, S.; Marino, M.; Mallol, J.; Canela, E. I.; Morimoto, C.; Callebaut, C.; Hovanessian, A.; Casado, V.; Lluis, C.; Franco, R. Regulation of epithelial and lymphocyte cell adhesion by adenosine deaminase-CD26 interaction Biochem. J. 2002, 361 (Pt 2) 203-9
63. Chen, E. I.; Florens, L.; Axelrod, F. T.; Monosov, E.; Barbas, C. F., III; Yates, J. R., III; Felding-Habermann, B.; Smith, J. W. Maspin alters the carcinoma proteome FASEB J. 2005, 19 (9) 1123-4
64. Zou, Z.; Anisowicz, A.; Hendrix, M. J.; Thor, A.; Neveu, M.; Sheng, S.; Rafidi, K.; Seftor, E.; Sager, R. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells Science 1994, 263 (5146) 526-9
65. Schleef, R. R.; Chuang, T. L. Protease inhibitor 10 inhibits tumor necrosis factor alpha -induced cell death. Evidence for the formation of intracellular high M(r) protease inhibitor 10-containing complexes J. Biol. Chem. 2000, 275 (34) 26385-9
66. Shioji, G.; Ezura, Y.; Nakajima, T.; Ohgaki, K.; Fujiwara, H.; Kubota, Y.; Ichikawa, T.; Inoue, K.; Shuin, T.; Habuchi, T.; Ogawa, O.; Nishimura, T.; Emi, M. Nucleotide variations in genes encoding plasminogen activator inhibitor-2 and serine proteinase inhibitor B10 associated with prostate cancer J. Hum. Genet. 2005, 50 (10) 507-15
67. Ulger, C.; Toruner, G. A.; Alkan, M.; Mohammed, M.; Damani, S.; Kang, J.; Galante, A.; Aviv, H.; Soteropoulos, P.; Tolias, P. P.; Schwalb, M. N.; Dermody, J. J. Comprehensive genome-wide comparison of DNA and RNA level scan using microarray technology for identification of candidate cancer-related genes in the HL-60 cell line Cancer Genet. Cytogenet. 2003, 147 (1) 28-35
68. Sullivan, D. C.; Huminiecki, L.; Moore, J. W.; Boyle, J. J.; Poulsom, R.; Creamer, D.; Barker, J.; Bicknell, R. EndoPDI, a novel protein-disulfide isomerase-like protein that is preferentially expressed in endothelial cells acts as a stress survival factor J. Biol. Chem. 2003, 278 (47) 47079-88
69. Wang, Y.; Ma, Y.; Lu, B.; Xu, E.; Huang, Q.; Lai, M. Differential expression of mimecan and thioredoxin domain-containing protein 5 in colorectal adenoma and cancer: a proteomic study Exp. Biol. Med. (Maywood, NJ, U.S.) 2007, 232 (9) 1152-9
70. Karihtala, P.; Mantyniemi, A.; Kang, S. W.; Kinnula, V. L.; Soini, Y. Peroxiredoxins in breast carcinoma Clin. Cancer Res. 2003, 9 (9) 3418-24
71. Chang, X. Z.; Li, D. Q.; Hou, Y. F.; Wu, J.; Lu, J. S.; Di, G. H.; Jin, W.; Ou, Z. L.; Shen, Z. Z.; Shao, Z. M. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer Breast Cancer Res. 2007, 9 (6) R76
72. Ho, J. N.; Lee, S. B.; Lee, S. S.; Yoon, S. H.; Kang, G. Y.; Hwang, S. G.; Um, H. D., Phospholipase A2 activity of peroxiredoxin 6 promotes invasion and metastasis of lung cancer cells. Mol. Cancer Ther. 2010, 9 (4), 825 - 32.
73. Cortesi, L.; Barchetti, A.; De Matteis, E.; Rossi, E.; Della Casa, L.; Marcheselli, L.; Tazzioli, G.; Lazzaretti, M. G.; Ficarra, G.; Federico, M.; Iannone, A. Identification of protein clusters predictive of response to chemotherapy in breast cancer patients J. Proteome Res. 2009, 8 (11) 4916-33
74. Kabat, G. C.; Rohan, T. E. Does excess iron play a role in breast carcinogenesis? An unresolved hypothesis Cancer Causes Control 2007, 18 (10) 1047-53
75. Arosio, P.; Ingrassia, R.; Cavadini, P. Ferritins: a family of molecules for iron storage, antioxidation and more Biochim. Biophys. Acta 2009, 1790 (7) 589-99
76. Ricolleau, G.; Charbonnel, C.; Lode, L.; Loussouarn, D.; Joalland, M. P.; Bogumil, R.; Jourdain, S.; Minvielle, S.; Campone, M.; Deporte-Fety, R.; Campion, L.; Jezequel, P. Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors Proteomics 2006, 6 (6) 1963-75
77. Zhao, S.; Lin, Y.; Xu, W.; Jiang, W.; Zha, Z.; Wang, P.; Yu, W.; Li, Z.; Gong, L.; Peng, Y.; Ding, J.; Lei, Q.; Guan, K. L.; Xiong, Y. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha Science 2009, 324 (5924) 261-5
78. Yan, H.; Parsons, D. W.; Jin, G.; McLendon, R.; Rasheed, B. A.; Yuan, W.; Kos, I.; Batinic-Haberle, I.; Jones, S.; Riggins, G. J.; Friedman, H.; Friedman, A.; Reardon, D.; Herndon, J.; Kinzler, K. W.; Velculescu, V. E.; Vogelstein, B.; Bigner, D. D. IDH1 and IDH2 mutations in gliomas N. Engl. J. Med. 2009, 360 (8) 765-73
79. Xu, S. G.; Yan, P. J.; Shao, Z. M. Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis. J. Cancer Res. Clin. Oncol. 2010.
80. Boult, J.; Roberts, K.; Brookes, M. J.; Hughes, S.; Bury, J. P.; Cross, S. S.; Anderson, G. J.; Spychal, R.; Iqbal, T.; Tselepis, C. Overexpression of cellular iron import proteins is associated with malignant progression of esophageal adenocarcinoma Clin. Cancer Res. 2008, 14 (2) 379-87
81. Brocklehurst, D.; Champion, A. E.; Cheek, T. R.; Dewhurst, D. G. The value of 6-phosphogluconate dehydrogenase (6-PGDH) activity as a marker of tumour cellularity and prognostic indicator in primary breast cancer Tumor Biol. 1986, 7 (2-3) 99-104
82. Wolf, I.; O'Kelly, J.; Rubinek, T.; Tong, M.; Nguyen, A.; Lin, B. T.; Tai, H. H.; Karlan, B. Y.; Koeffler, H. P. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer Cancer Res. 2006, 66 (15) 7818-23
83. Murayama, H.; Fukuda, Y.; Tsunekawa, S.; Ikemoto, M.; Nagata, A. Ratio of serum ornithine carbamoyltransferase to alanine aminotransferase as a potent indicator for hepatocellular carcinoma Clin. Biochem. 2007, 40 (13-14) 1077-80
84. Zhang, L.; Hou, Y.; Li, N.; Wu, K.; Zhai, J., The influence of TXNDC5 gene on gastric cancer cell. J. Cancer Res. Clin. Oncol. 2010.
85. Chan, C. M.; Wong, S. C.; Lam, M. Y.; Hui, E. P.; Chan, J. K.; Lo, E. S.; Cheuk, W.; Wong, M. C.; Tsao, S. W.; Chan, A. T. Proteomic comparison of nasopharyngeal cancer cell lines C666-1 and NP69 identifies down-regulation of annexin II and beta2-tubulin for nasopharyngeal carcinoma Arch. Pathol. Lab. Med. 2008, 132 (4) 675-83
86. Ito, T.; Shimada, Y.; Kan, T.; David, S.; Cheng, Y.; Mori, Y.; Agarwal, R.; Paun, B.; Jin, Z.; Olaru, A.; Hamilton, J. P.; Yang, J.; Abraham, J. M.; Meltzer, S. J.; Sato, F. Pituitary tumor-transforming 1 increases cell motility and promotes lymph node metastasis in esophageal squamous cell carcinoma Cancer Res. 2008, 68 (9) 3214-24
87. Zohrabian, V. M.; Nandu, H.; Gulati, N.; Khitrov, G.; Zhao, C.; Mohan, A.; Demattia, J.; Braun, A.; Das, K.; Murali, R.; Jhanwar-Uniyal, M. Gene expression profiling of metastatic brain cancer Oncol. Rep. 2007, 18 (2) 321-8
88. Marioni, G.; Staffieri, C.; Staffieri, A.; De Filippis, C.; Blandamura, S. MASPIN tumour-suppressing activity in head and neck squamous cell carcinoma: emerging evidence and therapeutic perspectives Acta Otolaryngol. 2009, 129 (5) 476-80
89. Mlakar, V.; Berginc, G.; Volavsek, M.; Stor, Z.; Rems, M.; Glavac, D. Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer BMC Cancer 2009, 9, 282
90. Ho, J. N.; Lee, S. B.; Lee, S. S.; Yoon, S. H.; Kang, G. Y.; Hwang, S. G.; Um, H. D. Phospholipase A2 activity of peroxiredoxin 6 promotes invasion and metastasis of lung cancer cells Mol. Cancer Ther. 2010, 9 (4) 825-32
91. Yang, H. J.; Chen, J. Z.; Zhang, W. L.; Ding, Y. Q. Focal adhesion plaque associated cytoskeletons are involved in the invasion and metastasis of human colorectal carcinoma Cancer Invest. 2010, 28 (2) 127-34